City View Green
  • City View (CVGR) has completed the second and final tranche of its non-brokered private placement for gross proceeds of $47,500
  • Under the second tranche, the company issued 3,166,667 common shares
  • City View is a consumer packaged goods company focusing on the development of cannabis-infused edibles
  • City View Green Holdings Inc. (CVGR) opened trading at C$0.01 per share

City View (CVGR) has completed the second and final tranche of its non-brokered private placement for gross proceeds of $47,500.

Under the second tranche, the company issued 3,166,667 common shares. Together with the first tranche closing, the company has raised a total of $372,500 in the offering.

No finder’s fees were paid in connection to this offering. All securities issued under the second tranche are subject to a statutory hold period expiring July 21, 2023.

Rob Fia, President, CEO and Director of the company (insider) also participated in the second tranche for $22,500.

About City View Green Holdings

City View is a consumer packaged goods company focusing on the development of cannabis-infused edibles. City View owns a 27.5 per cent stake in Budd Hutt Inc., a retail-focused cannabis company. It has access to cannabis cultivation and production licenses in Alberta and other retail opportunities across Canada.

City View Green Holdings Inc. (CVGR) opened trading at C$0.01 per share.

More From The Market Online

@ the Bell: TSX sees first positive day in a week

Canadian stock markets moved up on Wednesday as investors await fresh cues about timing of this year’s interest rate cuts
TC Energy - Shot from the NGTL pipeline system.

TC Energy’s latest fuel spill sparks wildfire

The NGTL natural gas pipeline, owned by TC Energy, ruptured and caused a wildfire 40 kilometres northwest of Edson, Alberta, Tuesday morning.
PyroGenesis - PyroGenesis' STP torch for refrigerant destruction, hydrocracking and heating.

PyroGenesis to help global mining leader lower emissions

PyroGenesis Canada (TSX:PYR) signs a contract with a global mining supplier to apply its electric plasma torches towards emissions reduction.

Canadian biotech stock investigates potential weight loss drugs

FSD Pharma Inc. (CSE:HUGE) is expanding its pipeline into metabolic and related disorders including weight loss and liver health.